AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
ORLANDO, FLA. -- When it comes to prescribing daily aspirin for the prevention or treatment of vascular events, the lowest risk of bleeding complications in a new metaanalysis involving more than 192,000 patients was seen at dosages that were less than 100 mg/day, Victor L. Serebruany, M.D., reported during the annual meeting of the American College of Cardiology.
The most surprising finding in this massive metaanalysis was not that lower aspirin doses are safer--"You don't need to be a rocket scientist to realize that," he said--but rather, that the bleeding risk climbed dramatically with dosages even in the moderate range of 100-200 mg/day. The analysis involved 31 randomized controlled trials published since 1988.
"We do not know if 75 mg/day of aspirin is better or worse than 325 mg in terms of efficacy, because there has been no direct comparative trial. However, now we know for sure that the lower the dose, the less the bleeding risk.... The absolutely practical, simple lesson is, if you are not sure that efficacy is actually different, use as low a dose as possible," stressed Dr. Serebruany, owner of HeartDrug Research, LLC, of Towson, Md.
Of the 31 trials included in the metaanalysis, 9 featured low-dose aspirin arms. Eight examined the impact of moderate-dose aspirin, defined by Dr. Serebruany as 100-200 mg/day. Nineteen had high-dose aspirin arms, involving daily doses greater than 200 mg.
The rate of major bleeding was around 1.5% in patients on low- or moderate-dose aspirin, rising to more than 5% in the high-dose ...